EME Stage 1 Guidance Notes
As part of NIHR response to the Government’s call for further reduction in bureaucracy the Stage 1 application has recently been reduced in scope. The changes include:
- Lead applicant: the lead applicant’s research background (publications and grants) are no longer required at this stage.
- History of application: information about the history of application is no longer required at this stage.
- Joint lead applicant: Less information is requested at this stage about the joint lead applicant.
Application summary information
Contracting (host) organisation
Please give details of the organisation who will be the contractor if the project is funded.
The project title should state clearly and concisely the proposed research. Any abbreviations should be spelled out in full.
Select the appropriate research type. If your proposed project includes any element of primary research, please select ‘Primary Research’. If you are carrying out new analysis of existing data, select ‘Secondary Research’. If you are not sure which category to select, choose the closest match to your project as this can be adjusted later.
Proposed start date
Note this should be from 1st of the month regardless of whether this is a working day or not. Please be realistic about your possible start date taking account of the necessary contracting, and staff recruitment prior to starting your project. HRA approval will not necessarily need to be in place before the start date. Funds can be released prior to ethical approval being obtained.
Research duration (months)
Ensure you include sufficient time to complete all aspects of the research including applications for regulatory approvals (where required) and the final report.
This field will automatically populate once you have saved the research duration information.
Estimated research costs
Enter the total amount of research costs requested (not including NHS Support & Treatment costs).
Estimated NHS support and treatment costs or external (not NHS) intervention costs
Enter the total amount of NHS support and treatment costs associated with this proposal.
For the EME Programme you should only need to include costs in the Research costs and NHS Support and Treatment costs boxes. Non-NHS intervention costs are similar to excess treatment costs but mainly apply to Public Health Research.
Complete your name, contact details and other requested information.
Specify your (lead applicant) role in this research (Limit: 200 characters)
Explain in addition to your role as Lead Applicant, the role that you will be undertaking in the research, e.g. co-ordination and project management, analysis, methodological input etc.
Lead applicant’s % FTE Commitment
Commitment: This refers to the percentage of your time that you will commit to this project.
The research team
Joint lead applicant
Where appropriate and justified it is acceptable for the application to be led by joint Lead Applicants.
Note: For application / contracting purposes the joint lead applicant will be regarded as a co-applicant.
Please click the ‘Add’ button and select the Joint Lead Applicant Role drop down option and enter their details (if applicable)
Justification for joint lead applicant (Limit: 1500 characters)
Justification should be given to demonstrate why more than one person would be required to lead this research and how this brings added value to the application.
Relevant expertise and experience of joint lead applicant (Limit: 1500 characters)
Please note: you are not required to complete this section as it is no longer required as part of a stage 1 application submission. However, as it is a mandatory field please enter N/A.
Joint lead applicant / co-applicants / co-applicants - PPI
Add details of all co-applicants (including Joint Lead Applicant if appropriate) and their specific role in the project. The number of co-applicants is calculated automatically. Do not include collaborators, who should be mentioned (if necessary) in the Research Plan section of the on-line application form.
For mechanisms of action of health interventions applications
Applicants must enter data sharing agreements with the owner(s) of any data required for the proposed mechanistic study and/or agreement from the CI of the original study if it was NIHR-funded. Letters of support can be uploaded as evidence at Stage 2.
We encourage the inclusion of public co-applicants, where appropriate. Please include a clear description of their role and the reasons why a public co-applicant is joining the team. For further information please access the 'Public co-applicants in research' guidance.
The role of the PPI lead can be undertaken by any of the co-applicants within the research team (or a named member of the team), who has the relevant skills, experience and authority to be accountable, represent, manage and embed patient and public involvement in all aspects of the research study/programme. This role should be a budgeted and resourced research team member. Examples of the activities a PPI lead might be accountable for.
The NIHR expects appropriate and and well-designed involvement of patients/service users, carers and the public and other key stakeholders in the research it supports. In the Stage 1 application, it is essential to show your plans for involving patients/service user, carers and the public at each appropriate stage of the research project lifecycle. For example, sitting on oversight committees, being a member of the research team involved in activities such as recruitment, data collection, analysis, producing study materials and sharing findings. Your PPI (patient and public involvement) plans will be assessed by the funding committee which includes patient and public members. In the rare circumstances where PPI is not appropriate, a clear justification must be provided.
You should also outline how PPI has informed the development of the project so far. For example, the involvement of patients/service user, carers or the public in shaping the research question and study design. These activities could include the development of feasible, relevant and acceptable recruitment plans, data collection tools, information materials, outcome measures, follow-up, intervention design and delivery.
For a Stage 2 application, you will be asked how the PPI will be managed, reported and evaluated so whilst it is not necessary to provide the detail in Stage 1, early consideration should be given to these aspects. Here are further resources to support the design of your PPI.
Plain Englishsummary of research
The importance of a plain English summary
A plain English summary is a clear explanation of your research.
Many reviewers use this summary to inform their review of your funding application. They include clinicians and other practitioners and researchers who do not have specialist knowledge of your field as well as members of the public. If your application for funding is successful, the summary will be used on National Institute for Health Research (NIHR) and other websites.
A good quality plain English summary providing an easy to read overview of your whole study will help:
• those carrying out the review (reviewers and board and panel members) to have a better understanding of your research proposal
• inform others about your research such as members of the public, health and social care professionals, policy makers and the media
• the research funders to publicise the research that they fund.
If it is felt that your plain English summary is not clear and of a good quality then you may be required to amend it prior to final funding approval. It is helpful to involve patients / carers / service users / practitioners and members of the public in developing a plain English summary.
When writing your summary consider including the following information where appropriate:
• aim(s) of the research
• background to the research
• design and methods used
• patient and public involvement
Further guidance on writing in plain English is available at NIHR Make it Clear. For further support and advice on writing a plain English summary, please contact your local Research Design Service (where applicable).
Using all of the headings (in the order presented) and guidance below, please use this section to clearly explain your proposed research. As this is the main part of your application which will be considered by the reviewing committee you should ensure that the information is accurate, succinct and clearly laid out. The overall amount of information that you can provide at this stage is limited to 4 pages (dependent on the type/complexity/scale of study proposed).
The NIHR expects appropriate and relevant involvement of patients/service users, carers and the public and other key stakeholders in the research it supports. It is essential to set out your plans to involve patients/service users, carers and the public in the Stage 1 application. Your patient and public involvement plans will be assessed by the funding panel/committee including patient/service users, carers and public members.
Information and resources to assist you can be found on the INVOLVE website (a detailed definition of patient and public involvement in research, briefing notes for researchers on how to involve patients/service users, carers and the public and an involvement cost calculator and budgeting guide).
In this section it is important that you identify all stakeholders who are relevant to your research proposal. For each stakeholder group you need to be clear about how they benefit from your proposed research and, where appropriate, how they have been involved in the development of the application, as well as the plans for their involvement in the proposed research.
Guidance for applicants on Equality, diversity and inclusion for study participants:
Every person eligible to take part in research should be offered the same opportunity of taking part in that research regardless of:
- Geographical location
- Gender reassignment
- Marriage and civil partnership
- Pregnancy and maternity
- Ethnicity - useful links (for example) to: The toolkit for increasing participation of BAME groups in health and care research
The INCLUDE Ethnicity Framework, which aims to improve trial delivery for under-served groups
- Sexual orientation
- Socioeconomic status
- Access to health or social care
All NIHR applications are expected to include information about how this data will be collected.
In addition, applicants should demonstrate how these factors have been considered and addressed in their proposal, including steps taken to ensure the research sample is representative of the population the study is targeted at. Applicants need to explain who they are planning to recruit to ensure inclusivity of study participants and justify and explain any exclusions, for example by completing an Equality Impact Assessment. Additionally, applicants should demonstrate that all potential recruiting locations have been considered and the research is deliverable to those areas.
Please see the NIHR INCLUDE Guidance for more information about how to include under-served groups effectively:
Other helpful links:
What is the problem being addressed?
Provide a clear explanation of the health or social care problem to be addressed, the impact on patients/service users, carers, as well as health and care services, and how this research would fill a demonstrable evidence gap.
Provide a brief explanation of:
- the unmet health need to be addressed
- the size of the incident or prevalent population
- your proposed innovation
- a justification of your choice of study design
- details of any mechanistic components
For studies of diagnostic or prognostic tests, please modify these headings as appropriate.
For mechanisms of action of health interventions applications
For stand alone mechanistic studies, applicants will need to make a strong case for how a better understanding of the mechanisms of action of the original intervention will potentially contribute to the future use or development of the technology, future wealth creation and for the ultimate benefit of individual patients or the wider NHS.
Why is this research important in terms of improving the health and/or wellbeing of the public and/or to patients and health and care services?
It is essential that you clearly identify the health and care need your research meets or contributes to. Please outline the anticipated value or contribution the study will provide. Explain the case for this research, and how it will meet the needs of the public/patients.
Review of existing evidence - How does the existing literature support this proposal?
Explain why this research is needed now, both in terms of time and relevance. We will only fund research where the proposed research is informed by a review of the existing evidence.
- Explain why this research is needed now. Please put your research into the context of current practice, other recent or ongoing research or time-limited opportunities.
- Provide information to show that you have reviewed all the directly relevant published literature.
- Give details of other trials or research currently underway, both nationally and internationally, which are relevant to the proposed study.
All proposals recommended for funding which involve a clinical trial will be double-checked for potential overlaps using WHO trials before the communication of any funding decision. Consequently, a funding recommendation may not be taken forward if a major overlap is identified at this stage. It is therefore important that applicants highlight any potential overlaps prior to consideration by the funding committee.
- Describe the evidence that provides proof of concept in man for your research. Please ensure you include references on proof of concept in your bibliography. More information about what proof of concept is required can be found in the EME remit.
- Explain how your research fits into the EME remit and the call to which you are applying.
What is the research question / aims and objectives?
Please summarise the research question / key aims and objectives.
- The aim (broad question) of your proposed research.
- For clinical trials, a single sentence describing the primary outcome measure.
- A numbered list of the clinical objectives (specific components).
- A numbered list of the mechanistic objectives where appropriate. Mechanistic components to studies are strongly encouraged. These must test a clear hypothesis and contain an indication of how the tests/measurements will confirm or refute this hypothesis. Examples of EME-funded studies with mechanistic components can also be found in the EME remit.
- For standalone mechanistic studies, please describe the hypothesis/hypotheses being tested. All applications must be hypothesis-driven, i.e. funding will not be available for hypothesis generating studies.
- The deliverables from the project, linked to the numbered list of objectives.
Provide an scientific summary of the project plan of investigation plus any additional points required to support statements made in the previous sections, and include any key references required to justify the points made (e.g. in the use of particular outcome measures or methods of analysis).
This gives you an opportunity to explain and elaborate on the information in questions 1-4. Please do not repeat information already given.
- Describe your study using an appropriate format for the design. An indication of time line and work sequence for staged projects is also needed. The EME Programme strongly encourages innovative study designs involving stratification, the use of routinely collected digital data or novel methodologies. Please ensure these elements are fully described and it is clear how the use of these approaches could help to speed up the translation of promising interventions and/or have the potential to increase the impact of the research.
If your research is a clinical trial, please base your summary on a PICO format, i.e. the study Population, planned Intervention, Comparison/control and Outcome measures. Most CTUs, RDS or R&D offices also have suitable templates, which can be used as a basis for your response.
If your research is not a clinical trial (for example, a validation of a diagnostic test or a standalone mechanistic study) provide a carefully structured project plan. At a minimum it should explain the source and availability of specimens/patients, the tests/interventions you plan to use, the controls or “gold standard” comparators, the statistical tests you plan to use and the expected differences that can be detected. For standalone mechanistic studies, Please provide the project number, title, funding programme and award dates of the study providing the patients/samples.
In addition to the above, you must include the following key information required by the EME Funding Committee:
- For randomised clinical trials a sample size with an associated power calculation. Information must be provided so the funding committee can replicate the calculation and understand the assumptions made.
- A recruitment plan including the approximate number of patients that would be likely to be available.
- A realistic indication of timelines for regulatory steps, team recruitment, patient recruitment, study completion, data analysis and write-up as well as the anticipated pathways to impact. This must be in text format, not a diagram. Please see: How to disseminate your research: Getting your message heard - and used.
- A description of the team that is proposed to deliver this research. The EME Programme expects to see a multidisciplinary team, which includes all relevant expertise to enable delivery of the proposed research, and promotes team science. If your application includes a mechanistic study, your study team must demonstrate the appropriate skills to support such a study.
- If the study involves a drug or other intervention clearly justify why this drug/intervention has been chosen over alternatives, and provide a justification for the dosing regimen/treatment schedule.
- For standalone mechanistic studies, provide a brief summary of the underlying study, setting out the population, intervention, comparator and outcomes. If the study has completed, describe the findings. If it is still underway, describe the current progress.
- A justification of how the project offers value for money.
Intellectual property and commercialisation
The definition of Intellectual Property (IP) includes copyright (such as new software, checklists, scales, protocols, questionnaires, toolkits, guidelines or similar) and research tools (such as data analysis techniques, assays, cell lines, biomarkers, materials or equipment and devices) patents, trademarks and designs.
- Please provide details of any existing or potential future intellectual property and ownership, including patents or patent applications that are relevant to the project.
- If commercial partners are involved in the study, a detailed description of the contributions and expectations from all parties must be included.
- If the study involves a drug or other intervention clearly justify why this drug/intervention has been chosen over alternatives.
It is important to include details of how you will share with study participants the progress and findings of the study. For more information please read how to disseminate your research: Getting your message heard - and used.
Previous history of application
If this EME application is a resubmission for which you previously received feedback, please explain what you learned and how the application has improved. If this EME application is pending a decision from another funder, please give details of the funder, and the expected decision date.
Attachment 1: flow diagram
Finally, please create a flow diagram (single-side of A4), as a separate PDF file, for submission with your application form. This should illustrate the study design and the flow of participants. Applicants should also describe complex interventions and controls as accurately and fully as possible within their diagram. If proposing an RCT, we advise you refer to the CONSORT statement and website for guidance. Alternatively, you may find the EQUATOR Network website useful. The PDF file should be submitted along with your application form.
Attachment 2: references
One single-side A4 page, listing references used throughout your proposal is also a mandatory upload. Please use either the Vancouver or Harvard referencing conventions, and include the DOI of the main related publication.
Attachment 3: papers in press
You may include relevant in-press publication that provides proof of concept. Please provide detail of when this was submitted and to which journal.
Acknowledge, review and submit
Please declare any conflicts or potential conflicts of interest that you or your co-applicants may have in undertaking this research, including any relevant, non-personal and commercial interest that could be perceived as a conflict of interest.
Agreement to terms and conditions
I have read and understood the terms on which I have been nominated as Chief Investigator for this proposal along with the associated documentation and accept this role. Read the full terms and conditions.
Equality and diversity monitoring information
NIHR is committed to promoting equality, diversity and inclusion in research and asks applicants to provide equality and diversity monitoring information (age, sex, ethnicity and race, and disability). By answering these questions, you will help us to better understand the different groups of people that apply to us for funding and their experiences of the funding process – particularly the groups protected by UK equality legislation. Although it is mandatory to answer these questions, it is possible to select “prefer not to say” as a response. However, the more information you provide, the more effective our monitoring will be. This information will not be used to make decisions about funding.
Checklist of information to include when submitting a NIHR stage 1 research application
Applicants should click the check boxes to indicate that they have included the necessary information prior to submitting their application.
- A good quality Plain English Summary (at NIHR Make it Clear)
- A clear explanation of the problem being addressed
- A clear demonstration of the need and importance of the research
- A review of existing literature (primary research)
- A clear research question / aim(s) and objectives
- A clear project plan summarising the study design and methods
- A clear description of team member roles and contribution
- Appropriate and relevant involvement of patients/service user, carers and the public
- A clear, appropriate and relevant plan for dissemination
- A flow diagram illustrating the study design / flow of participants (document upload)
- One single-side A4 page of references using either the Vancouver or Harvard referencing conventions (document upload)